These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36717607)

  • 1. Association between pharmacologic treatment and hospital utilization at birth among neonatal opioid withdrawal syndrome mother-infant dyads.
    Hahn PD; Melvin P; Graham DA; Ozonoff A; Milliren CE
    J Perinatol; 2023 Mar; 43(3):283-292. PubMed ID: 36717607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental methadone exposure and risk of Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Jing X; Wang X; Zhu HJ
    Pharmacotherapy; 2024 Jan; 44(1):22-27. PubMed ID: 37574548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
    Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
    Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
    Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
    JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Methodology to Create Mother-Baby Dyads Using Data From the Pediatric Health Information System.
    Hahn PD; Melvin P; Graham DA; Milliren CE
    Hosp Pediatr; 2022 Oct; 12(10):884-892. PubMed ID: 36168855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial.
    Devlin LA; Hu Z; Merhar SL; Ounpraseuth ST; Simon AE; Lee JY; Das A; Crawford MM; Greenberg RG; Smith PB; Higgins RD; Walsh MC; Rice W; Paul DA; Maxwell JR; Fung CM; Wright T; Ross J; McAllister JM; Crowley M; Shaikh SK; Christ L; Brown J; Riccio J; Wong Ramsey K; Braswell EF; Tucker L; McAlmon K; Dummula K; Weiner J; White JR; Newman S; Snowden JN; Young LW;
    JAMA Pediatr; 2024 Jun; 178(6):525-532. PubMed ID: 38619854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
    Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
    BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.
    Sankaran D; Rawat S; Kachelmeyer JL; Li ES; Reynolds AM; Rawat M; Chandrasekharan P
    Am J Perinatol; 2024 May; 41(S 01):e654-e663. PubMed ID: 35973797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
    Velez ML; Jordan CJ; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics.
    Schwartz AN; Meschke LL
    Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Mortality Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Austin AE; Di Bona V; Cox ME; Proescholdbell SK; Naumann RB
    Am J Prev Med; 2022 Oct; 63(4):619-623. PubMed ID: 35489960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome.
    Kuzniewicz MW; Campbell CI; Li S; Walsh EM; Croen LA; Comer SD; Pimentel SD; Hedderson M; Sun LS
    J Perinatol; 2023 Mar; 43(3):293-299. PubMed ID: 36131095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.